Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TXG
#1647
10x Genomics, Inc. Class A Common Stock
24.800
0
USD
+5.17%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+5.17%
Monthly Change
+29.71%
6 month change
+79.45%
Year Change
+79.45%
Previous Close
23.580
0
Open
24.800
0
Bid
Ask
Low
24.800
0
High
24.800
0
Volume
195
Markets
US Stock Market
Healthcare
TXG
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
108.75 M
112.84 M
115.36 M
119.17 M
122.3 M
127.75 M
—
Valuation ratios
Enterprise value
14.8 B
16.22 B
3.86 B
6.11 B
1.41 B
1.61 B
4.4 B
Price to earnings ratio
—
-281.06
-24.2
-24.91
-9.45
-46.6
-88.71
Price to sales ratio
—
33.51
7.79
10.28
2.83
3.17
9.29
Price to cash flow ratio
—
-769.07
-119.7
-418.64
259.56
14.96
71.37
Price to book ratio
—
20.11
4.99
8.59
2.44
2.56
3.89
Enterprise value to EBITDA ratio
-28.33
-521.02
-27.04
-26.59
-8.9
-64.94
-104.16
Profitability ratios
Return on assets %
-0.58
-0.06
-0.16
-0.26
-0.2
-0.04
-0.05
Return on equity %
-0.73
-0.07
-0.21
-0.34
-0.26
-0.05
-0.06
Return on invested capital %
-1 096.79
-75.34
-154.45
-210.69
-166.94
-59.57
-56.72
Gross margin %
80.44
84.89
76.69
66.15
67.86
69.05
275.83
Operating margin %
-178.74
-10.65
-32.52
-42.88
-31.85
-9.49
-41.38
EBITDA margin %
-174.05
-6.35
-27.61
-37.14
-25.98
-3.86
-18.71
Net margin %
-181.61
-11.87
-32.15
-41.23
-29.9
-6.77
-30.43
Liquidity ratios
Quick ratio
6.3
6.23
4.23
4.11
4.26
4.09
18.06
Current ratio
6.56
6.77
4.85
4.69
4.97
4.46
20.15
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.39
0.5
0.5
0.62
0.65
0.66
0.66
Solvency ratios
Debt to assets ratio
0.07
—
—
—
—
—
—
Debt to equity ratio
0.09
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.19
-0.3
-0.13
0.06
1.09
1.09
EBIT per share
—
-0.47
-1.48
-2.26
-1.62
-0.49
-0.49
EBITDA per share
—
-0.28
-1.25
-1.96
-1.32
-0.2
-0.2
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
5.32
3.78
3.32
3.27
4.2
15.11
Net current asset value per share
—
6.77
5.58
5.09
4.85
5.49
20.74
Tangible book value per share
—
7.14
6.84
6.14
5.73
5.85
23.21
Working capital per share
—
5.77
4.43
4
3.88
4.26
16.55
Book value per share
—
7.41
7.08
6.32
5.9
6.38
24.62
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
News
Stock Picks From Seeking Alpha's March 2026 New Analysts
Canada stocks higher at close of trade; S&P/TSX Composite up 0.58%
Tempus AI Reinforces Market Position With Collaborations in 2026
10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG)
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
10X Genomics stock falls on Microsoft AI spatial tool concerns
Micron and Intel among market cap stock movers on Monday
10x Genomics stock tumbles as ARK Invest dumps shares
Cathie Wood’s ARK stock trades highlight CRISPR buys, 10x Genomics sells
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS - TipRanks.com
JOBY, DKNG: Cathie Wood Adds More Joby Aviation and DraftKings Shares - TipRanks.com
Cathie Wood’s ARK trims 10X Genomics stock, adds DraftKings